Get Full access to Top 1000 data, subscribe from only €29

Ipsen Manufacturing

Add to comparison

Ipsen is a biotechnological group aiming to become a leader in specialty healthcare solutions for debilitating diseases. Its strategy is supported by three franchises, neurology, endocrinology and urology-oncology. Ipsen has a growing portfolio in prostate cancer, bladder cancer or neuro-endocrine tumours and a presence in primary care. The group has more than 4,500 employees spread across R&D and manufacturing sites located in China, France, Ireland, the UK and the US.

Financial Data

31st Dec 16 Source: CRO
- €103 million turnover
- €85.7 million profit
- 111 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
31st Dec 15 Source: CRO
- €89.4 million turnover
- €74.3 million profit
- 99 employees
- Auditor: KPMG
- Audit Fees: Purchase access »
- Non-Audit Fees: Purchase access »
- Tax On Profit: Purchase access »
4 more years available »